April 25–30, 2025 | Chicago, IL | Booth #1656
Pelago Bioscience is exhibiting at the AACR Annual Meeting 2025, where oncology and drug discovery professionals gather to share the latest scientific advances. Visit us in Chicago at Booth #1656 to learn how our CETSA® technology supports drug discovery with biologically relevant data on target engagement, selectivity, and mechanism of action.
Our team will present four scientific posters at AACR this year—showcasing how CETSA is applied across diverse research areas, including PROTACs, p53-targeted compounds, and large-scale selectivity profiling.
Our R&D, project advisory, and US sales experts will be available throughout the event to connect, answer questions, and discuss how CETSA can support your research.
Want to meet with us at AACR?
Schedule time with a member of our team by using the link below.
Poster Presentations
CETSA-based evaluation of non-degraded PROTAC targets
Session: Degraders and Glues 1
Date: April 27, 2025 | Time: 2:00–5:00 PM
Location: Poster Section 18, Board 27
Abstract #408
Explore how CETSA can identify non-degraded targets that remain bound and functionally relevant in degrader studies.
New hit compounds for p53 identified with a CETSA-based high-throughput screen
Session: High-Throughput Screening Assays and Libraries
Date: April 28, 2025 | Time: 2:00–5:00 PM
Location: Poster Section 25, Board 15
Abstract #3162
See how CETSA enables high-throughput discovery of new compounds directly in cells.
Dissecting the biology of mutant p53 with the Cellular Thermal Shift Assay (CETSA)
Session: Gene Regulation and Transcription Factors 2
Date: April 28, 2025 | Time: 9:00 AM–12:00 PM
Location: Poster Section 10, Board 10
Abstract #1413
Learn how CETSA can help unravel the biology of challenging oncology targets like mutant p53.
A standardized drug selectivity profiling platform with a proteome coverage of more than 5,000 proteins
Session: New Nonclinical Models for Targets
Date: April 30, 2025 | Time: 9:00 AM–12:00 PM
Location: Poster Section 20, Board 14
Abstract #6853
Discover how our CETSA-based platform delivers large-scale selectivity insights early in development.
The Pelago Bioscience team includes representatives from R&D (Tomas Friman, Daniel Martinez Molina), project advising (Helena Almqvist, Agata Habas, Julia Popp), US sales (Dan Campbell, Steve Kosteski, Brian Jarecki) and our CEO – Michael Dabrowski. We look forward to seeing you there.
Book a meeting with us at AACR 2025
For more information about the conference, visit the AACR Annual Meeting 2025 website.